161416-94-0 Usage
General Description
(R)-3-(pyrrolidin-2-ylmethoxy)pyridine is a chemical compound with a molecular formula C11H15NO and a molecular weight of 177.24 g/mol. It is a pyridine derivative with a pyrrolidinylmethoxy group attached to the 3-position of the pyridine ring. (R)-3-(PYRROLIDIN-2-YLMETHOXY)PYRIDINE has potential pharmaceutical applications due to its ability to interact with nicotinic acetylcholine receptors in the central nervous system. It may also have potential as a ligand in medicinal chemistry research for the development of new drugs targeting these receptors. Additionally, it has been studied for its potential use as a cholinergic agonist in the treatment of neurological and psychiatric disorders. However, further research is needed to fully understand its pharmacological properties and potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 161416-94-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,4,1 and 6 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 161416-94:
(8*1)+(7*6)+(6*1)+(5*4)+(4*1)+(3*6)+(2*9)+(1*4)=120
120 % 10 = 0
So 161416-94-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H14N2O/c1-3-9(12-6-1)8-13-10-4-2-5-11-7-10/h2,4-5,7,9,12H,1,3,6,8H2/t9-/m1/s1
161416-94-0Relevant articles and documents
N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: Synthesis, in vitro activity, and molecular modeling studies
Chu, Wenhua,Zhang, Jun,Zeng, Chenbo,Rothfuss, Justin,Tu, Zhude,Chu, Yunxiang,Reichert, David E.,Welch, Michael J.,Mach, Robert H.
, p. 7637 - 7647 (2007/10/03)
A number of isatin sulfonamide analogues were prepared and their potencies for inhibiting caspase-1, -3, -6, -7, and -8 were evaluated in vitro. Several compounds displaying a nanomolar potency for inhibiting the executioner caspases, caspase-3 and caspas
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release
-
, (2008/06/13)
Novel heterocyclic ether compounds of the formula: STR1 wherein n, *, R1, R2, R3 and y are specifically defined, or pharmaceutically acceptable salts or prodrugs thereof, which are useful in selectively controlling neurotransmitter release; therapeutically-effective pharmaceutical compositions of these compounds; and use of said compositions to selectively control neurotransmitter release in mammals.
